InvestorsHub Logo
Followers 1
Posts 971
Boards Moderated 0
Alias Born 02/14/2018

Re: fbg0316 post# 99145

Friday, 05/24/2019 1:08:54 PM

Friday, May 24, 2019 1:08:54 PM

Post# of 108191
NEO was billed ADXS' next gen (i.e. last hope). That all changed when Amgen saw the initial data and bailed.

If drug companies could tell whether a drug would be successful or not after only 2 or 3 patients are dosed in a P1, we wouldn't have as many P2/P3 trials happening and costs for bringing a drug to market w/their associated trials would be much, much lower.

I will say Amgen leaving was disastrous and Advaxis won't last flipping the bill for it much longer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News